BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38017005)

  • 1. Genomic and transcriptomic characterization of pre-operative chemotherapy response in patients with osteosarcoma.
    Yang Y; Huang Z; Yuan M; Rui J; Chen R; Jin T; Sun Y; Deng Z; Shan H; Niu X; Liu W
    Sci Rep; 2023 Nov; 13(1):20914. PubMed ID: 38017005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of osteosarcoma that can predict response to chemotherapy.
    Man TK; Chintagumpala M; Visvanathan J; Shen J; Perlaky L; Hicks J; Johnson M; Davino N; Murray J; Helman L; Meyer W; Triche T; Wong KK; Lau CC
    Cancer Res; 2005 Sep; 65(18):8142-50. PubMed ID: 16166288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
    Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
    J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden.
    Zheng S; Wang F; Huang J; Zhou Y; Yang Q; Qian G; Zhou C; Min D; Song L; Shen Z
    Front Endocrinol (Lausanne); 2021; 12():625226. PubMed ID: 34220700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular classification of osteosarcoma.
    Lau CC
    Cancer Treat Res; 2009; 152():459-65. PubMed ID: 20213408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
    Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
    Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
    Du X; Yang J; Yang D; Tian W; Zhu Z
    BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Scoring Criteria for Preoperative Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma.
    Hashimi M; Hasan O; An Q; Miller BJ
    Iowa Orthop J; 2021 Dec; 41(2):19-26. PubMed ID: 34924866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values.
    Li M; Cheng WT; Li H; Zhang Z; Lu XL; Deng SS; Li J; Yang CH
    Curr Med Sci; 2021 Oct; 41(5):916-929. PubMed ID: 34671904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences and perspectives on adjuvant chemotherapy in osteogenic osteosarcoma].
    Jasmin C; Delépine G; Delépine N; Trifaud A; Mathé G
    Biomed Pharmacother; 1986; 40(5):167-9. PubMed ID: 3466653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
    Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
    Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma.
    Iwata S; Tatsumi Y; Yonemoto T; Araki A; Itami M; Kamoda H; Tsukanishi T; Hagiwara Y; Kinoshita H; Ishii T; Nagase H; Ohira M
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
    Barenboim M; Kovac M; Ameline B; Jones DTW; Witt O; Bielack S; Burdach S; Baumhoer D; Nathrath M
    PLoS Comput Biol; 2021 Nov; 17(11):e1009562. PubMed ID: 34762643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proteome predicts chemotherapy response in osteosarcoma patients.
    Li Y; Dang TA; Shen J; Hicks J; Chintagumpala M; Lau CC; Man TK
    Oncol Rep; 2011 Feb; 25(2):303-14. PubMed ID: 21165584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.
    Ho XD; Phung P; Q Le V; H Nguyen V; Reimann E; Prans E; Kõks G; Maasalu K; Le NT; H Trinh L; G Nguyen H; Märtson A; Kõks S
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1802-1811. PubMed ID: 29050494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.
    Sadikovic B; Thorner P; Chilton-Macneill S; Martin JW; Cervigne NK; Squire J; Zielenska M
    BMC Cancer; 2010 May; 10():202. PubMed ID: 20465837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment.
    Jiang Y; Wang J; Sun M; Zuo D; Wang H; Shen J; Jiang W; Mu H; Ma X; Yin F; Lin J; Wang C; Yu S; Jiang L; Lv G; Liu F; Xue L; Tian K; Wang G; Zhou Z; Lv Y; Wang Z; Zhang T; Xu J; Yang L; Zhao K; Sun W; Tang Y; Cai Z; Wang S; Hua Y
    Nat Commun; 2022 Nov; 13(1):7207. PubMed ID: 36418292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma.
    Tesser-Gamba F; Paolillo AT; Del Giúdice Paniago M; Petrilli AS; Seixas Alves MT; Garcia Filho RJ; Toledo SRC
    Ann Diagn Pathol; 2020 Jun; 46():151482. PubMed ID: 32145682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.